These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12067545)

  • 41. Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.
    Cheng XC; Wang Q; Fang H; Tang W; Xu WF
    Bioorg Med Chem; 2008 May; 16(10):5398-404. PubMed ID: 18440232
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Two antiviral compounds from the plant Stylogne cauliflora as inhibitors of HCV NS3 protease.
    Hegde VR; Pu H; Patel M; Das PR; Butkiewicz N; Arreaza G; Gullo VP; Chan TM
    Bioorg Med Chem Lett; 2003 Sep; 13(17):2925-8. PubMed ID: 14611859
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of human cytomegalovirus protease N(o) with monocyclic beta-lactams.
    Déziel R; Malenfant E
    Bioorg Med Chem Lett; 1998 Jun; 8(11):1437-42. PubMed ID: 9871780
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Discovery of novel P3-oxo inhibitor of hepatitis C virus NS3/4A serine protease.
    Duan M; Kazmierski W; Crosby R; Gartland M; Ji J; Tallant M; Wang A; Hamatake R; Wright L; Wu M; Zhang YK; Ding CZ; Li X; Liu Y; Zhang S; Zhou Y; Plattner JJ; Baker SJ
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2993-6. PubMed ID: 22425454
    [TBL] [Abstract][Full Text] [Related]  

  • 45. (3R,4S)-4-(2,4,5-Trifluorophenyl)-pyrrolidin-3-ylamine inhibitors of dipeptidyl peptidase IV: synthesis, in vitro, in vivo, and X-ray crystallographic characterization.
    Wright SW; Ammirati MJ; Andrews KM; Brodeur AM; Danley DE; Doran SD; Lillquist JS; Liu S; McClure LD; McPherson RK; Olson TV; Orena SJ; Parker JC; Rocke BN; Soeller WC; Soglia CB; Treadway JL; Vanvolkenburg MA; Zhao Z; Cox ED
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5638-42. PubMed ID: 17822893
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recent advances in the development of MMPIs and APNIs based on the pyrrolidine platforms.
    Li X; Li J
    Mini Rev Med Chem; 2010 Aug; 10(9):794-805. PubMed ID: 20482497
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis of potent pyrrolidine influenza neuraminidase inhibitors.
    Krueger AC; Xu Y; Kati WM; Kempf DJ; Maring CJ; McDaniel KF; Molla A; Montgomery D; Kohlbrenner WE
    Bioorg Med Chem Lett; 2008 Mar; 18(5):1692-5. PubMed ID: 18242993
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Boceprevir, an NS3 protease inhibitor of HCV.
    Berman K; Kwo PY
    Clin Liver Dis; 2009 Aug; 13(3):429-39. PubMed ID: 19628159
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structural variations in keto-glutamines for improved inhibition against hepatitis A virus 3C proteinase.
    Jain RP; Vederas JC
    Bioorg Med Chem Lett; 2004 Jul; 14(14):3655-8. PubMed ID: 15203137
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Design and synthesis of cyclic inhibitors of matrix metalloproteinases and TNF-alpha production.
    Xue CB; He X; Roderick J; DeGrado WF; Cherney RJ; Hardman KD; Nelson DJ; Copeland RA; Jaffee BD; Decicco CP
    J Med Chem; 1998 May; 41(11):1745-8. PubMed ID: 9599225
    [No Abstract]   [Full Text] [Related]  

  • 51. The discovery of novel potent trans-3,4-disubstituted pyrrolidine inhibitors of the human aspartic protease renin from in silico three-dimensional (3D) pharmacophore searches.
    Lorthiois E; Breitenstein W; Cumin F; Ehrhardt C; Francotte E; Jacoby E; Ostermann N; Sellner H; Kosaka T; Webb RL; Rigel DF; Hassiepen U; Richert P; Wagner T; Maibaum J
    J Med Chem; 2013 Mar; 56(6):2207-17. PubMed ID: 23425156
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New prolyl oligopeptidase inhibitors developed from dicarboxylic acid bis(l-prolyl-pyrrolidine) amides.
    Wallén EA; Christiaans JA; Jarho EM; Forsberg MM; Venäläinen JI; Männistö PT; Gynther J
    J Med Chem; 2003 Oct; 46(21):4543-51. PubMed ID: 14521416
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pyrimido[1,2-b]-1,2,4,5-tetrazin-6-ones as HCMV protease inhibitors: a new class of heterocycles with flavin-like redox properties.
    Di Grandi MJ; Curran KJ; Baum EZ; Bebernitz G; Ellestad GA; Ding WD; Lang SA; Rossi M; Bloom JD
    Bioorg Med Chem Lett; 2003 Oct; 13(20):3483-6. PubMed ID: 14505653
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The introduction of P4 substituted 1-methylcyclohexyl groups into Boceprevir: a change in direction in the search for a second generation HCV NS3 protease inhibitor.
    Bennett F; Huang Y; Hendrata S; Lovey R; Bogen SL; Pan W; Guo Z; Prongay A; Chen KX; Arasappan A; Venkatraman S; Velazquez F; Nair L; Sannigrahi M; Tong X; Pichardo J; Cheng KC; Girijavallabhan VM; Saksena AK; Njoroge FG
    Bioorg Med Chem Lett; 2010 Apr; 20(8):2617-21. PubMed ID: 20303756
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structure-activity study on a novel series of macrocyclic inhibitors of the hepatitis C virus NS3 protease leading to the discovery of BILN 2061.
    Llinàs-Brunet M; Bailey MD; Bolger G; Brochu C; Faucher AM; Ferland JM; Garneau M; Ghiro E; Gorys V; Grand-Maître C; Halmos T; Lapeyre-Paquette N; Liard F; Poirier M; Rhéaume M; Tsantrizos YS; Lamarre D
    J Med Chem; 2004 Mar; 47(7):1605-8. PubMed ID: 15027850
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Potent cationic inhibitors of West Nile virus NS2B/NS3 protease with serum stability, cell permeability and antiviral activity.
    Stoermer MJ; Chappell KJ; Liebscher S; Jensen CM; Gan CH; Gupta PK; Xu WJ; Young PR; Fairlie DP
    J Med Chem; 2008 Sep; 51(18):5714-21. PubMed ID: 18729351
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discovery of novel P2 substituted 4-biaryl proline inhibitors of hepatitis C virus NS3 serine protease.
    Bailey MD; Halmos T; Lemke CT
    Bioorg Med Chem Lett; 2013 Aug; 23(15):4436-40. PubMed ID: 23773864
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel 3-(2-adamantyl)pyrrolidines with potent activity against influenza A virus-identification of aminoadamantane derivatives bearing two pharmacophoric amine groups.
    Stamatiou G; Kolocouris A; Kolocouris N; Fytas G; Foscolos GB; Neyts J; De Clercq E
    Bioorg Med Chem Lett; 2001 Aug; 11(16):2137-42. PubMed ID: 11514155
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Macrocyclic inhibitors of the NS3 protease as potential therapeutic agents of hepatitis C virus infection.
    Tsantrizos YS; Bolger G; Bonneau P; Cameron DR; Goudreau N; Kukolj G; LaPlante SR; Llinàs-Brunet M; Nar H; Lamarre D
    Angew Chem Int Ed Engl; 2003 Mar; 42(12):1356-60. PubMed ID: 12671967
    [No Abstract]   [Full Text] [Related]  

  • 60. 1-((S)-gamma-substituted prolyl)-(S)-2-cyanopyrrolidine as a novel series of highly potent DPP-IV inhibitors.
    Sakashita H; Kitajima H; Nakamura M; Akahoshi F; Hayashi Y
    Bioorg Med Chem Lett; 2005 May; 15(10):2441-5. PubMed ID: 15863294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.